Online ISSN: 2331-4737
www.oncoscience.us
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

LEARN MORE ABOUT ONCOSCIENCE

Oncoscience | A Case for Routine Evaluation of HER2 Expression in Ductal Carcinoma In Situ

News

February 17, 2023
PRESS RELEASE: On January 30, 2023, Oncoscience published a new editorial paper: “HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!” continue reading »

Oncoscience | A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL)

News

January 23, 2023
PRESS RELEASE: On October 24, 2022, a new research perspective was published in Oncoscience, entitled, “A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL).” continue reading »

Oncoscience | Association between tumor mutations and meningioma recurrence in Grade I/II disease

News

January 17, 2023
PRESS RELEASE: On December 9, 2022, a new research paper was published in Oncoscience, entitled, “Association between tumor mutations and meningioma recurrence in Grade I/II disease.” continue reading »

Oncoscience | Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective

News

December 27, 2022
PRESS RELEASE: On December 21, 2022, a new research perspective was published in Oncoscience, entitled, “Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective.” continue reading »